The Global Active Pharmaceutical Ingredients Market was Valued at $176.3 Billion in 2018, and is Anticipated to Reach $247.2 Billion by 2024 - ResearchAndMarkets.com

DUBLIN--()--The "Active Pharmaceutical Ingredients Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2019-2024" report has been added to ResearchAndMarkets.com's offering.

The global active pharmaceutical ingredients market was worth US$ 176.3 Billion in 2018. Looking forward, the market value is projected to reach US$ 247.2 Billion by 2024, exhibiting a CAGR of 5.8% during 2019-2024.

The global demand of APIs is currently exhibiting strong growth. One of the major drivers of this market is the rising number of blockbuster patent expiries creating a significant opportunity for generic APIs. Moreover, there has been a strong demand for APIs for biologicals.

The global market for biologicals is currently exhibiting strong growth catalyzed by their high potency and ability to treat diseases beyond the scope of small molecule drugs. This is creating a strong demand for APIs for branded biological drugs and their biosimilar versions.

Other factors catalyzing the global demand of APIs include ageing population, rising expenditures on healthcare, increasing prevalence of lifestyle diseases, etc.

The global API market is extremely competitive with a number of large and small manufacturers. Firms that engage in API manufacturing generally specialize and target their manufacturing based on a combination of the firms in-house skills and market opportunities.

Catalyzed by lower costs, API manufacturing has gradually been shifting from the historical leaders in Western countries to manufacturers based in India and China.

Key Questions Answered

  • How has the global active pharmaceutical ingredients market performed so far and how will it perform in the coming years?
  • What are the key regional markets in the global active pharmaceutical ingredients industry?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of drug type?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of type of manufacturer?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of synthesis?
  • What is the breakup of the global active pharmaceutical ingredients market on the basis of therapeutic application?
  • What are the various stages in the value chain of the global active pharmaceutical ingredients market?
  • What are the key driving factors and challenges in the global active pharmaceutical ingredients market?
  • What is the structure of the global active pharmaceutical ingredients market and who are the key players?
  • What is the degree of competition in the global active pharmaceutical ingredients market?
  • How are active pharmaceutical ingredients manufactured?

Topics Covered

1 Preface

2 Scope and Methodology

2.1 Objectives of the Study

2.2 Stakeholders

2.3 Data Sources

2.4 Market Estimation

2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

4.1 Overview

4.2 Key Industry Trends

5 Global Active Pharmaceutical Ingredients Market

5.1 Market Overview

5.2 Market Performance

5.3 Market Breakup by Drug Type

5.4 Market Breakup by Type of Manufacturer

5.5 Market Breakup by Type of Synthesis

5.6 Market Breakup by Therapeutic Application

5.7 Market Breakup by Region

5.8 Market Forecast

5.9 SWOT Analysis

5.10 Value Chain Analysis

5.11 Porters Five Forces Analysis

5.12 Price Analysis

6 Market Breakup by Drug Type

6.1 Innovative Active Pharmaceutical Ingredients

6.2 Generic Active Pharmaceutical Ingredients

7 Market Breakup by Type of Manufacturer

7.1 Captive Manufacturers

7.2 Merchant API Manufacturers

8 Market Breakup by Type of Synthesis

8.1 Synthetic Active Pharmaceutical Ingredients

8.2 Biotech Active Pharmaceutical Ingredients

9 Market Breakup by Therapeutic Application

9.1 Oncology

9.2 Cardiovascular Disease

9.3 Diabetes

9.4 Central Nervous System and Neurological Disorders

9.5 Endocrinology

9.6 Others

10 Market Breakup by Region

10.1 North America

10.2 Europe

10.3 Asia Pacific

10.4 Middle East and Africa

10.5 Latin America

11 Manufacturing Process

11.1 Product Overview

11.2 Raw Material Requirements

11.3 Manufacturing Process

11.4 Key Success and Risk Factors

12 Competitive Landscape

12.1 Market Structure

12.2 Key Players

12.3 Profiles of Key Players

12.3.1 Pfizer Inc.

12.3.2 Novartis International AG

12.3.3 Sanofi

12.3.4 Boehringer Ingelheim

12.3.5 Bristol-Myers Squibb

12.3.6 Teva Pharmaceutical Industries Ltd.

12.3.7 ELI Lilly and Company

12.3.8 GlaxoSmithKline

12.3.9 Merck & Co. Inc.

12.3.10 Abbvie Inc.

For more information about this report visit https://www.researchandmarkets.com/research/qqwf24/the_global_active?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Intermediates

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Press Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Pharmaceutical Intermediates